These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33108705)

  • 1. Up-regulation of FoxO1 contributes to adverse vascular remodelling in type 1 diabetic rats.
    Liu J; Xie X; Yan D; Wang Y; Yuan H; Cai Y; Luo J; Xu A; Huang Y; Cheung CW; Irwin MG; Xia Z
    J Cell Mol Med; 2020 Dec; 24(23):13727-13738. PubMed ID: 33108705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RING finger protein 10 is a potential drug target for diabetic vascular complications.
    Li S; Yu G; Huang W; Wang R; Pu P; Chen M
    Mol Med Rep; 2019 Aug; 20(2):931-938. PubMed ID: 31173254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse vascular remodelling is more sensitive than endothelial dysfunction to hyperglycaemia in diabetic rat mesenteric arteries.
    Kahlberg N; Qin CX; Anthonisz J; Jap E; Ng HH; Jelinic M; Parry LJ; Kemp-Harper BK; Ritchie RH; Leo CH
    Pharmacol Res; 2016 Sep; 111():325-335. PubMed ID: 27363948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of Adiponectin Ameliorates Nonalcoholic Fatty Liver Disease via Inhibition of FoxO1 in Type I Diabetic Rats.
    Xie X; Yan D; Li H; Zhu Q; Li J; Fang YP; Cheung CW; Irwin MG; Xia Z; Lian Q
    J Diabetes Res; 2018; 2018():6254340. PubMed ID: 30186875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglycaemia correlates with skeletal muscle capillary regression and is associated with alterations in the murine double minute-2/forkhead box O1/thrombospondin-1 pathway in type 1 diabetic BioBreeding rats.
    Aiken J; Mandel ER; Riddell MC; Birot O
    Diab Vasc Dis Res; 2019 Jan; 16(1):28-37. PubMed ID: 30360646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXO1 plays an important role in enhanced microvascular cell apoptosis and microvascular cell loss in type 1 and type 2 diabetic rats.
    Behl Y; Krothapalli P; Desta T; Roy S; Graves DT
    Diabetes; 2009 Apr; 58(4):917-25. PubMed ID: 19168598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXO1 contributes to diabetic cardiomyopathy via inducing imbalanced oxidative metabolism in type 1 diabetes.
    Yan D; Cai Y; Luo J; Liu J; Li X; Ying F; Xie X; Xu A; Ma X; Xia Z
    J Cell Mol Med; 2020 Jul; 24(14):7850-7861. PubMed ID: 32450616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXO1 inhibition potentiates endothelial angiogenic functions in diabetes via suppression of ROCK1/Drp1-mediated mitochondrial fission.
    Shi Y; Fan S; Wang D; Huyan T; Chen J; Chen J; Su J; Li X; Wang Z; Xie S; Yun C; Li X; Tie L
    Biochim Biophys Acta Mol Basis Dis; 2018 Jul; 1864(7):2481-2494. PubMed ID: 29654945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative vascular responses three months after paclitaxel and everolimus-eluting stent implantation in streptozotocin-induced diabetic porcine coronary arteries.
    Sheehy A; Hsu S; Bouchard A; Lema P; Savard C; Guy LG; Tai J; Polyakov I
    Cardiovasc Diabetol; 2012 Jun; 11():75. PubMed ID: 22716997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXO1 impairs whereas statin protects endothelial function in diabetes through reciprocal regulation of Kruppel-like factor 2.
    Lee HY; Youn SW; Cho HJ; Kwon YW; Lee SW; Kim SJ; Park YB; Oh BH; Kim HS
    Cardiovasc Res; 2013 Jan; 97(1):143-52. PubMed ID: 23002242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin receptor protease-activated receptor 4 is a key regulator of exaggerated intimal thickening in diabetes mellitus.
    Pavic G; Grandoch M; Dangwal S; Jobi K; Rauch BH; Doller A; Oberhuber A; Akhyari P; Schrör K; Fischer JW; Fender AC
    Circulation; 2014 Nov; 130(19):1700-11. PubMed ID: 25239438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of FoxO1/ PGC-1α prevents mitochondrial dysfunction and ameliorates mesangial cell injury in diabetic rats.
    Wu L; Wang Q; Guo F; Zhou Y; Ji H; Liu F; Ma X; Zhao Y; Qin G
    Mol Cell Endocrinol; 2015 Sep; 413():1-12. PubMed ID: 26123583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXO1 reduces STAT3 activation and causes impaired mitochondrial quality control in diabetic cardiomyopathy.
    Zhou L; Su W; Wang Y; Zhang Y; Xia Z; Lei S
    Diabetes Obes Metab; 2024 Feb; 26(2):732-744. PubMed ID: 37961034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology of Human Coronary and Carotid Artery Atherosclerosis and Vascular Calcification in Diabetes Mellitus.
    Yahagi K; Kolodgie FD; Lutter C; Mori H; Romero ME; Finn AV; Virmani R
    Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):191-204. PubMed ID: 27908890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for MRP8 in in stent restenosis in diabetes.
    Stocca A; O'Toole D; Hynes N; Hynes SO; Mashayekhi K; McGinley L; O'Connell E; Coleman C; Sultan S; Duffy A; Tunev S; O'Brien T
    Atherosclerosis; 2012 Apr; 221(2):325-32. PubMed ID: 22381691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual effects of fructose on ChREBP and FoxO1/3α are responsible for AldoB up-regulation and vascular remodelling.
    Cao W; Chang T; Li XQ; Wang R; Wu L
    Clin Sci (Lond); 2017 Feb; 131(4):309-325. PubMed ID: 28007970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
    Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
    Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear receptor Nur77 inhibits vascular outward remodelling and reduces macrophage accumulation and matrix metalloproteinase levels.
    Bonta PI; Matlung HL; Vos M; Peters SL; Pannekoek H; Bakker EN; de Vries CJ
    Cardiovasc Res; 2010 Aug; 87(3):561-8. PubMed ID: 20189954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal diabetes increases FOXO1 activation during embryonic cardiac development.
    Sato H; Leonardi ML; Roberti SL; Jawerbaum A; Higa R
    Mol Cell Endocrinol; 2023 Sep; 575():111999. PubMed ID: 37391062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tribbles 3: A potential player in diabetic aortic remodelling.
    Ti Y; Xie GL; Wang ZH; Ding WY; Zhang Y; Zhong M; Zhang W
    Diab Vasc Dis Res; 2016 Jan; 13(1):69-80. PubMed ID: 26410836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.